Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$5.98
-1.40%
Mkt Cap $610.09M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+184.5%
Consensus $17.00 vs current $5.98
NASDAQ·Healthcare·Biotechnology
$5.98
-1.40%
Mkt Cap $610.09M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+184.5%
Consensus $17.00 vs current $5.98